| Establishment | February 15, 1968 | |
| Capital | 2,100 million yen | |
| Directors | Representative Director
Chairman and President | Dr. Karl Roeser |
| Director
Head of Performance Materials Pigments & Cosmetics Division | Hiroshi Ashizawa | |
Director
| Ikuko Kajikawa | |
| Director
Chief Financial Officer Head of Administration Division | Koji Okamoto | |
| Auditor | Eiji Wakayama | |
| Parent Company | Merck Internationale Beteiligungen GmbH (Germany) : 72.4%
Merck KGaA (Germany) : 15.9% Millipore International Holding Company B.V. (The Netherlands) : 11.7% | |
| Main Bank | Deutsche Bank AG, Tokyo Branch | |
| Subsidiary | Biotest K.K.
http://www.biotest.co.jp/ | |